Recursion Pharmaceuticals, Inc. revenue breakdown overview

Recursion Pharmaceuticals, Inc. revenue for the last year amounted to 58.49 M USD, the most of which — 58.84 M USD — came from its highest performing source at the moment, Drug Discovery, the year earlier bringing 44.58 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Recursion Pharmaceuticals, Inc. 58.84 M USD, and the year before that — 44.58 M USD.